Abbott Laboratories (ABT) Minority Interest (2009 - 2026)

Abbott Laboratories has disclosed Minority Interest across 18 years of filings, most recently posting $652.0 million for Q2 2026.

• In Q2 2026, Minority Interest rose 146.97% year-over-year to $652.0 million; the TTM figure through Jun 2026 stood at $652.0 million (up 146.97% YoY), while the FY2025 annual figure was $641.0 million, up 170.46% from the prior year.
• Minority Interest came in at $652.0 million for Q2 2026 at Abbott Laboratories, up from $640.0 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $652.0 million in Q2 2026 to a low of $209.0 million in Q3 2022.
• Average Minority Interest over 5 years is $304.3 million, with a median of $232.5 million recorded in 2024.
• Year-over-year, Minority Interest slipped 3.48% in 2023 and surged 170.46% in 2025.
• Over 5 years, Minority Interest stood at $219.0 million in 2022, then increased by 2.28% to $224.0 million in 2023, then climbed by 5.8% to $237.0 million in 2024, then surged by 170.46% to $641.0 million in 2025, then increased by 1.72% to $652.0 million in 2026.
• Per Business Quant data, the three most recent Minority Interest figures were $652.0 million in Q2 2026, $640.0 million in Q1 2026, and $641.0 million in Q4 2025.